CRISPR Pumps the Brakes on the Immune System to Support Gene Therapies

The ability to edit the human genome using CRISPR has been heralded as a revolution in medicine. However, one of the biggest challenges facing gene therapies is getting this molecule gene-editing machinery into cells. Among the most common delivery approaches is the use of viruses such as the adeno-associated virus (AAV), which shuttle CRISPR into the nuclei of cells…

--

--

--

Follow me for bite-sized stories on the latest discoveries and innovations in biomedical research.

Love podcasts or audiobooks? Learn on the go with our new app.

Recommended from Medium

Is there a God?

subaqueous states

New gene therapy shows promise, but is it enough to reverse aging?

A Brief Introduction to Quantum Computing

Scientists may have found the keystone use for graphene oxide

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
River D'Almeida, Ph.D

River D'Almeida, Ph.D

Follow me for bite-sized stories on the latest discoveries and innovations in biomedical research.

More from Medium

World First: Pigs Cloned by Robots

Gut Microbes Help Squirrels Maintain Muscle While Hibernating

What Sentient Chatbots Could Mean for the Field of Telemedicine

What Do Mirror Images And Chirality Have To Do With The Biochemistry In Our Body?